Deborah Alderson will provide guidance on how SRA can penetrate new markets and expand its customer accounts.
Divestiture part of SRA's strategy to focus on its core capabilities.
SRA International Inc. has sold its contract research organization, SRA Global Clinical Development LLC, to biopharmaceutical Aptiv Solutions Inc. for an undisclosed sum.
Former SRA International Inc. President and CEO Stanton Sloane wasted little time finding a new home. He's taken the reins of a California advanced security company.
SRA International Inc. and four other contractors have been named to the Veterans Affairs Department’s $480 million Veterans Relationship Management program.
Company taps a veteran of the defense contracting world to lead the company.
SRA CEO Stanton Sloane warns about the growing danger the theft of intellectual property poses to our economy and national security.
The $1.88 billion all-cash sale of SRA International Inc. to an affiliate of Providence Equity Partners has been completed. SRA founder Ernst Volgenau will continue to serve as chairman of the SRA Board.
Acquisition by Providence Equity Partners expected to close in next three months.
SRA International Inc. will continue supporting the Drug Enforcement Administration, having successfully won the recompeted 10-year, $72.9 million Firebird Infrastructure Technology Services II contract.
Companies will now compete to help VA improve communications with veterans.
SRA International Inc. saw revenue grow almost 10 percent over the same quarter last year. What's behind their growth?